RBR-8vyvnmb尚未招募2 期
se of Liraglutide to treat Covid19 pneumonia: A Phase II open-label, single center safety study with biomarker profiling
niversidade Federal de São Paulo - Disciplina de Pneumologia0 个研究点开始时间: 2020年12月9日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 0（—）
入选标准
- •Aged over 18 years old; Covid19 pneumonia admitted to hospital less than forty-eight hours including those within a critical care setting
排除标准
- •Anticipated eligibility for extracorporeal membrane oxigenation support in subsequent 72h; life expectancy less than 48h estimated by one or members of the clinical team; impaired liver function, defined as alanine aminotransferase more than 3 times the upper limit of normal; impaired renal function, defined as an estimated glomerular filtration rate less than 30 mL/min/1.73m2; active pancreatitis; known allergy to liraglutide; pregnancy or lactation
研究者
相似试验
招募中
2 期
The effect of Liraglutide on clinical and paraclinical symptoms in patients with polycystic ovary syndromeIRCT20220720055510N1Shahre-kord University of Medical Sciences35
已完成
3 期
The efficacy and safety of liraglutide as adjunct therapy to insulin in the treatment of type 1 diabetes; A 52-week randomised, treat-to-target, placebo-controlled, double-blinded, parallelgroup, multinational, multi-centre trial10018424diabetesNL-OMON38605ovo Nordisk50
进行中（未招募）
1 期
The efficacy and safety of liraglutide as adjunct therapy to insulin in the treatment of type 1 diabetesDiabetes Mellitus, Type 1MedDRA version: 16.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-003580-21-NOovo Nordisk A/S1,398
进行中（未招募）
1 期
The efficacy and safety of liraglutide as adjunct therapy to insulin in the treatment of type 1 diabetesDiabetes Mellitus, Type 1EUCTR2012-003580-21-BEovo Nordisk A/S1,398
进行中（未招募）
不适用
The efficacy and safety of liraglutide as adjunct therapy to insulin in the treatment of type 1 diabetesDiabetes Mellitus, Type 1MedDRA version: 16.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-003580-21-SEovo Nordisk A/S1,404